Nirmatrelvir plus ritonavir in patients with underlying rheumatological diseases, in preventing COVID-19 related hospitalization and death.

MLA

Javed, Faiza, et al. “Nirmatrelvir plus Ritonavir in Patients with Underlying Rheumatological Diseases, in Preventing COVID-19 Related Hospitalization and Death.” Advances in Rheumatology (London, England), vol. 64, no. 1, July 2024, p. 50. EBSCOhost, https://doi.org/10.1186/s42358-024-00388-6.

APA

Javed, F., Mangino, A. A., & Piranavan, P. (2024). Nirmatrelvir plus ritonavir in patients with underlying rheumatological diseases, in preventing COVID-19 related hospitalization and death. Advances in Rheumatology (London, England), 64(1), 50. https://doi.org/10.1186/s42358-024-00388-6

Chicago

Javed, Faiza, Anthony A Mangino, and Paramarajan Piranavan. 2024. “Nirmatrelvir plus Ritonavir in Patients with Underlying Rheumatological Diseases, in Preventing COVID-19 Related Hospitalization and Death.” Advances in Rheumatology (London, England) 64 (1): 50. doi:10.1186/s42358-024-00388-6.